VYNE Therapeutics Inc. VYNE
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2018-01-25
VYNE Therapeutics Inc. institutional holders (13F)
| Investor | Shares | Value |
|---|---|---|
| CITADEL ADVISORS LLC | 514,443 | $307,380 |
| TWO SIGMA INVESTMENTS, LP | 426,412 | $254,781 |
| BlackRock Finance, Inc. | 60,581 | $119,345 |
| RENAISSANCE TECHNOLOGIES LLC | 17,300 | $10,337 |
Source: SEC EDGAR filings · CIK 0001566044 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.